Efficacy and safety of lebrikizumab in adult patients with mild-to-moderate asthma not receiving inhaled corticosteroids

Article ID	Journal	Published Year	Pages	File Type
8820014	Respiratory Medicine	2018	7 Pages	PDF

Abstract

This trial was registered under NCT02104674 at http://www.clinicaltrials.gov.

Keywords

FEV1 MMRM PEF ISR ICS ATA lebrikizumab SABA FeNO HLT mITT Asthma Short-acting β2-agonist modified intent-to-treat fractional exhaled nitric oxide interleukin Preferred term Peak expiratory flow forced expiratory volume in 1 s Moderate SOC MILD adverse event Pharmacokinetics injection site reaction System organ class Inhaled corticosteroids

Related Topics

Health Sciences Medicine and Dentistry Pulmonary and Respiratory Medicine

Preview

Efficacy and safety of lebrikizumab in adult patients with mild-to-moderate asthma not receiving inhaled corticosteroids

Authors

Philip Korenblat, Edwin Kerwin, Igor Leshchenko, Karl Yen, Cecile T.J. Holweg, Judith Anzures-Cabrera, Carmen Martin, Wendy S. Putnam, Laura Governale, Julie Olsson, John G. Matthews,